vTv Therapeutics (VTVT) Operating Leases (2019 - 2025)
vTv Therapeutics' (VTVT) quarterly Operating Leases came in at $125000.0 in Q1 2025, down 58.05% year-on-year from $298000.0 in Q1 2024, and down 26.04% quarter-over-quarter from $169000.0 in Q4 2024.
vTv Therapeutics (VTVT) Operating Leases (2019 - 2025) Analysis & Trends
vTv Therapeutics has disclosed Operating Leases across 7 years of filings, most recently posting $125000.0 for Q1 2025.
- Operating Leases for Q1 2025 came in at $125000.0, down 58.05% year-over-year; the trailing twelve-month figure through Mar 2025 was $125000.0 (down 58.05% YoY), and the FY2024 annual result was $169000.0, changed 0.0% from the prior year.
- Operating Leases came in at $125000.0 for Q1 2025 at vTv Therapeutics, down from $169000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $633000.0 in Q1 2021 to a low of $79000.0 in Q2 2024.
- The 5-year median for Operating Leases is $333000.0 (2022), against an average of $336941.2.
- Across the five-year window, Operating Leases increased 2.95% in 2023 and slumped 69.14% in 2024, its largest moves.
- vTv Therapeutics' Operating Leases stood at $492000.0 in 2021, then slumped by 31.3% to $338000.0 in 2022, then slumped by 50.0% to $169000.0 in 2023, then changed by 0.0% to $169000.0 in 2024, then declined by 26.04% to $125000.0 in 2025.
- The last three Operating Leases figures came in at $125000.0 (Q1 2025), $169000.0 (Q4 2024), and $213000.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | vTv Therapeutics | 426.76 Mn | 426.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 125,000.00 |
| Dec 31, 2024 | 169,000.00 |
| Sep 30, 2024 | 213,000.00 |
| Jun 30, 2024 | 79,000.00 |
| Mar 31, 2024 | 298,000.00 |
| Dec 31, 2023 | 169,000.00 |
| Sep 30, 2023 | 213,000.00 |
| Jun 30, 2023 | 256,000.00 |
| Mar 31, 2023 | 454,000.00 |
| Dec 31, 2022 | 338,000.00 |
| Sep 30, 2022 | 333,000.00 |
| Jun 30, 2022 | 388,000.00 |
| Mar 31, 2022 | 441,000.00 |
| Dec 31, 2021 | 492,000.00 |
| Sep 30, 2021 | 540,000.00 |
| Jun 30, 2021 | 587,000.00 |
| Mar 31, 2021 | 633,000.00 |
| Dec 31, 2020 | 676,000.00 |
| Sep 30, 2020 | 717,000.00 |
| Jun 30, 2020 | 756,000.00 |